Acadian Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.33M | Sell |
371,772
-298,589
| -45% | -$2.67M | 0.01% | 690 |
|
|
2025
Q1 | $5.02M | Buy |
670,361
+475,564
| +244% | +$3.56M | 0.01% | 497 |
|
|
2024
Q4 | $1.46M | Buy |
194,797
+183,472
| +1,620% | +$1.38M | ﹤0.01% | 846 |
|
|
2024
Q3 | $85K | Buy |
+11,325
| New | +$85K | ﹤0.01% | 1644 |
|
|
2020
Q3 | – | Sell |
-15,932
| Closed | -$76K | – | 2170 |
|
|
2020
Q2 | $76K | Sell |
15,932
-175,832
| -92% | -$839K | ﹤0.01% | 1790 |
|
|
2020
Q1 | $383K | Buy |
+191,764
| New | +$383K | ﹤0.01% | 1031 |
|